Acorda Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
10.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.10
|
-0.57
|
-0.47
|
-470.00%
|
|
2022-06-30
|
-0.36
|
-2.78
|
-2.42
|
-672.22%
|
|
2022-03-31
|
-0.39
|
-1.93
|
-1.54
|
-394.87%
|
|
2021-12-31
|
-1.11
|
-1.73
|
-0.62
|
-55.86%
|
|
2021-09-30
|
-1.56
|
-1.43
|
0.13
|
8.33%
|
|
2021-06-30
|
-2.09
|
-1.87
|
0.22
|
10.53%
|
|
2021-03-31
|
-2.54
|
-2.46
|
0.08
|
3.15%
|
|
2020-12-31
|
-1.48
|
-2.50
|
-1.02
|
-68.92%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-5.28
|
|
2021-12-31
|
-7.49
|
|
2020-12-31
|
-9.04
|
|
2019-12-31
|
-10.32
|
|
2018-12-31
|
4.41
|
|
2017-12-31
|
1.25
|
|
2016-12-31
|
0.15
|
|
2015-12-31
|
1.05
|
|
2014-12-31
|
0.63
|
|
2013-12-31
|
0.39
|
|
2012-12-31
|
0.61
|
|
2011-12-31
|
1.27
|
|
2010-12-31
|
-0.34
|
|
2009-12-31
|
-2.22
|
|
2008-12-31
|
-2.19
|
|
2007-12-31
|
-1.43
|
|
2006-12-31
|
-4.87
|